You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Etiology of device-associated infections per birth weight category in surveilled neonates

From: Surveillance of healthcare-associated infections in a neonatal intensive care unit in Italy during 2006–2010

Umbilical catheter associated bloodstream infection ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Candida parapsilosis 3 1 2 0 0 6 (50)
Escherichia coli 0 0 0 2 1 3 (25)
Candida albicans 1 0 0 0 1 2(16.7)
CONS 0 1 0 0 0 1 (8.3)
Total (% within BW category) 4 (33.3) 2 (16.7) 2 (16.7) 2 (16.7) 2 (16.7) 12 (100)
Central catheter associated bloodstream infection ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Candida parapsilosis 3 4 5 2 3 17 (35.4)
Candida albicans 1 3 0 2 1 7 (14.6)
Escherichia coli 0 4 0 0 0 4 (8.3)
Pseudomonas aeruginosa 3 1 0 0 0 4 (8.3)
Klebsiella pneumoniae ESBL+ 0 0 1 2 0 3 (6.3)
Serratia marcescens 2 1 0 0 0 3 (6.3)
CONS 0 0 2 0 0 2 (4.2)
Candida glabrata 0 0 1 0 0 1 (2.1)
Enterobacter spp. 0 1 0 0 0 1 (2.1)
Enterococcus faecalis 0 0 1 0 0 1 (2.1)
Not determined 0 0 1 0 0 1 (2.1)
polimicrobial (Candida albicans + Pseudomonas aeruginosa) 1 0 0 0 0 1 (2.1)
Rothia mucillaginosa 0 0 0 0 1 1 (2.1)
Staphylococcus aureus 0 0 0 1 0 1 (2.1)
Streptococcus spp. 1 0 0 0 0 1 (2.1)
Total (% within BW category) 11 (22.9) 14 (29.2) 11 (22.9) 7 (14.6) 5 (10.4) 48 (100)
VAP ≤750 g 751-1000 g 1001-1500 g 1501-2500 g >2500 g Total (%)
Pseudomonas aeruginosa 5 7 0 1 2 15 (41.7)
Acinetobacter baumannii 2 1 1 0 0 4 (11.1)
CONS 0 2 1 0 1 4 (11.1)
Klebsiella pneumoniae ESBL+ 1 2 1 0 0 4 (11.1)
Candida albicans 1 1 0 0 0 2 (5.6)
Escherichia coli 1 1 0 0 0 2 (5.6)
Not determined 1 0 0 1 0 2 (5.6)
Polimicrobial (K. pneumoniae ESBL+ + P. aeruginosa) 0 0 0 1 0 1 (2.8)
Staphylococcus aureus 0 1 0 0 0 1 (2.8)
Stenotrophomonas maltophilia 0 1 0 0 0 1 (2.8)
Total (% within BW category) 11 (30.6) 16 (44.4) 3 (8.3) 3 (8.3) 3 (8.3) 36 (100)
  1. Abbreviations: NICU, neonatal intensive care unit; CONS, coagulase negative staphylococci; ESBL+, extended spectrum beta-lactamase producer; VAP, ventilator-associated pneumonia.